CD163 and neoplasm: The chemokine ligand 15 (CXCL15) and the soluble protein cluster of differentiation 163 (sCD163), as surrogate indicators of Th17 cell and tumor-associated macrophage activation, respectively, have been proposed as biomarkers for irAE prediction [121].